PE20140406A1 - Moleculas bifuncionales con actividad de reclutamiento de anticuerpos y actividad inhibitoria inicial contra el virus de la inmunodeficiencia humana - Google Patents
Moleculas bifuncionales con actividad de reclutamiento de anticuerpos y actividad inhibitoria inicial contra el virus de la inmunodeficiencia humanaInfo
- Publication number
- PE20140406A1 PE20140406A1 PE2013001206A PE2013001206A PE20140406A1 PE 20140406 A1 PE20140406 A1 PE 20140406A1 PE 2013001206 A PE2013001206 A PE 2013001206A PE 2013001206 A PE2013001206 A PE 2013001206A PE 20140406 A1 PE20140406 A1 PE 20140406A1
- Authority
- PE
- Peru
- Prior art keywords
- immunodeficiency virus
- human immunodeficiency
- against human
- bifunctional molecules
- inhibitory activity
- Prior art date
Links
- 241000725303 Human immunodeficiency virus Species 0.000 title 1
- 230000001588 bifunctional effect Effects 0.000 title 1
- 230000000694 effects Effects 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 230000007115 recruitment Effects 0.000 title 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical group C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 150000001721 carbon Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000002391 heterocyclic compounds Chemical class 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
REFERIDA A UN COMPUESTO HETEROCICLICO DE FORMULA (A), DONDE ABT ES UN EXTREMO DE UNION A ANTICUERPO QUE COMPRENDE UN HAPTENO; LINKER ES UNA MOLECULA ENLAZADORA LA CUAL ENLAZA QUIMICAMENTE ABT A RY O DIRECTAMNETE AL GRUPO INDOL EN EL ATOMO DE CARBONO AL CUAL RY SE ENCUENTRA UNIDO; ARYL ES UN GRUPO AROMATICO O HETEROAROMATICO; RY ES O, NHC(O)NH, S(O)2O, ENTRE OTROS; X2 ES H, (CH2)nOH, (CH2)nCOOH, ENTRE OTROS; X3 ES H, (CH2)nOH, (CH2)nCOOH, ENTRE OTROS; R1 ES H O ALQUILO C1-C3; i ES 0 O 1; k ES 0, 1, 2 O 3; n ES 0 O UN ENTERO DE 1 A 6; Y3 ES H O ALQUILO C1-C3; RN ES H O ALQUILO C1-C3 OPCIONALMENTE SUSTITUIDO CON O O HALOGENO. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON INHIBIDORES DEL VIH
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41497710P | 2010-11-18 | 2010-11-18 | |
| US201161522518P | 2011-08-11 | 2011-08-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20140406A1 true PE20140406A1 (es) | 2014-04-16 |
Family
ID=46084646
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2013001206A PE20140406A1 (es) | 2010-11-18 | 2011-11-17 | Moleculas bifuncionales con actividad de reclutamiento de anticuerpos y actividad inhibitoria inicial contra el virus de la inmunodeficiencia humana |
Country Status (16)
| Country | Link |
|---|---|
| US (5) | US9562038B2 (es) |
| EP (1) | EP2640720B1 (es) |
| JP (2) | JP6155193B2 (es) |
| KR (1) | KR20140000275A (es) |
| CN (2) | CN103402998B (es) |
| AU (1) | AU2011329829B2 (es) |
| BR (1) | BR112013012309A2 (es) |
| CA (1) | CA2818308A1 (es) |
| CL (1) | CL2013001429A1 (es) |
| CO (1) | CO6801635A2 (es) |
| EA (1) | EA201390726A1 (es) |
| IL (1) | IL226397B (es) |
| MX (1) | MX350974B (es) |
| PE (1) | PE20140406A1 (es) |
| SG (2) | SG190829A1 (es) |
| WO (1) | WO2012068366A2 (es) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2206702T3 (da) | 2001-08-08 | 2012-02-13 | Tobira Therapeutics Inc | Bicyklisk forbindelse, fremstilling og anvendelse deraf |
| WO2011046946A2 (en) * | 2009-10-13 | 2011-04-21 | Yale University | Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus |
| SG190829A1 (en) | 2010-11-18 | 2013-07-31 | Univ Yale | Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus |
| US20140308342A1 (en) | 2011-11-11 | 2014-10-16 | Yale University | Reprogramming urokinase into an antibody-recruiting anticancer agent |
| WO2013162757A1 (en) | 2012-04-26 | 2013-10-31 | Yale University | Cytotoxic-drug delivering molecules targeting hiv (cdm-hs), cytotoxic activity against the human immunodeficiency virus and methods of use |
| US9556167B2 (en) | 2012-05-02 | 2017-01-31 | Yale University | TLR-agonist-conjugated antibody recruiting molecules (TLR-ARMs) |
| US10117943B2 (en) | 2013-05-03 | 2018-11-06 | Yale University | Synthetic antibody mimetic compounds (SYAMS) targeting cancer, especially prostate cancer |
| BR112017013130A2 (pt) * | 2014-12-23 | 2017-12-26 | Tobira Therapeutics Inc | processo de fabricação de cenicriviroc e análogos relacionados |
| WO2017023994A1 (en) | 2015-08-06 | 2017-02-09 | Yale University | Small molecule based antibody-recruiting compounds for cancer treatment |
| EA202091898A1 (ru) | 2015-12-15 | 2021-06-22 | Джилид Сайэнс, Инк. | Антитела, нейтрализующие вирус иммунодефицита человека |
| AU2017235571B2 (en) * | 2016-03-18 | 2024-05-16 | Georgetown University | Targeting tumor cells with chemotherapeutic agents conjugated to anti-matriptase antibodies by in vivo cleavable linking moieties |
| JP2019520427A (ja) | 2016-06-21 | 2019-07-18 | トビラ セラピューティクス， インコーポレイテッド | 精製されたセニクリビロク及びセニクリビロク製造のための精製された中間体 |
| WO2018026997A1 (en) | 2016-08-03 | 2018-02-08 | Yale University | Antibody-recruiting molecules for the treatment of cancer |
| EP3506896A4 (en) | 2016-08-31 | 2020-08-26 | Tobira Therapeutics, Inc. | SOLID FORMS OF CENICRIVIROC MESYLATE AND METHOD FOR MANUFACTURING SOLID FORMS OF CENICRIVIROC MESYLATE |
| CN107056762B (zh) * | 2016-12-22 | 2020-08-28 | 四川百利药业有限责任公司 | 一种用作抗流感病毒的双羰基类似物 |
| AU2018290228B2 (en) | 2017-06-21 | 2021-07-01 | Gilead Sciences, Inc. | Multispecific antibodies that target HIV gp120 and CD3 |
| CN113197912B (zh) * | 2020-01-30 | 2023-02-03 | 沈阳福洋医药科技有限公司 | 异戊酰螺旋霉素类化合物及其组合物在制备抗病毒药物中的应用 |
| CN111995622B (zh) * | 2020-08-20 | 2022-04-15 | 复旦大学 | 化合物及其用途 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| ZA893284B (en) * | 1988-05-04 | 1990-03-28 | Igen Inc | Peptide analogs and their use as haptens to elicit catalytic antibodies |
| CA2134239C (en) * | 1992-06-09 | 2004-11-23 | Donald B. Axworthy | Pretargeting methods and compounds |
| JP3319073B2 (ja) * | 1993-08-24 | 2002-08-26 | 和光純薬工業株式会社 | 免疫学的測定方法 |
| US6140505A (en) * | 1995-03-10 | 2000-10-31 | G. D. Searle & Co. | Synthesis of benzo fused heterocyclic sulfonyl chlorides |
| US6469006B1 (en) * | 1999-06-15 | 2002-10-22 | Bristol-Myers Squibb Company | Antiviral indoleoxoacetyl piperazine derivatives |
| US6573262B2 (en) * | 2000-07-10 | 2003-06-03 | Bristol-Myers Sqibb Company | Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives |
| ES2250422T3 (es) * | 2000-07-10 | 2006-04-16 | Bristol-Myers Squibb Company | Composicion y actividad antiviral de derivados de piperazina indoloxoaceticos sustituidos. |
| US6825201B2 (en) * | 2001-04-25 | 2004-11-30 | Bristol-Myers Squibb Company | Indole, azaindole and related heterocyclic amidopiperazine derivatives |
| HUP0401523A3 (en) * | 2004-07-29 | 2007-05-02 | Richter Gedeon Vegyeszet | Indole-2-carboxamide derivatives, pharmaceutical compositions containing them and process for producing them |
| ES2491743T3 (es) * | 2006-11-01 | 2014-09-08 | Ventana Medical Systems, Inc. | Haptenos, conjugados de haptenos, composiciones de los mismos y método para su preparación y uso |
| HUE025618T2 (en) * | 2008-05-13 | 2016-04-28 | Univ Yale | Kimer small molecules to select antibodies against cancer cells |
| EP2318051A4 (en) * | 2008-07-14 | 2012-12-26 | Andrew Metters | IN VITRO DIAGNOSTIC MARKERS COMPRISING CARBON NANOPARTICLES AND KITS |
| WO2010093706A2 (en) * | 2009-02-10 | 2010-08-19 | The Scripps Research Institute | Chemically programmed vaccination |
| WO2011046946A2 (en) | 2009-10-13 | 2011-04-21 | Yale University | Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus |
| WO2012019003A1 (en) * | 2010-08-06 | 2012-02-09 | Bristol-Myers Squibb Company | Substituted indole and azaindole oxoacetyl piperazinamide derivatives |
| SG190829A1 (en) * | 2010-11-18 | 2013-07-31 | Univ Yale | Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus |
-
2011
- 2011-11-17 SG SG2013038344A patent/SG190829A1/en unknown
- 2011-11-17 EA EA201390726A patent/EA201390726A1/ru unknown
- 2011-11-17 AU AU2011329829A patent/AU2011329829B2/en active Active
- 2011-11-17 JP JP2013540011A patent/JP6155193B2/ja active Active
- 2011-11-17 CN CN201180065404.3A patent/CN103402998B/zh active Active
- 2011-11-17 BR BR112013012309A patent/BR112013012309A2/pt not_active Application Discontinuation
- 2011-11-17 MX MX2013005462A patent/MX350974B/es active IP Right Grant
- 2011-11-17 PE PE2013001206A patent/PE20140406A1/es not_active Application Discontinuation
- 2011-11-17 US US13/988,251 patent/US9562038B2/en active Active
- 2011-11-17 WO PCT/US2011/061174 patent/WO2012068366A2/en not_active Ceased
- 2011-11-17 EP EP11842404.3A patent/EP2640720B1/en active Active
- 2011-11-17 SG SG10201510402WA patent/SG10201510402WA/en unknown
- 2011-11-17 KR KR1020137015098A patent/KR20140000275A/ko not_active Ceased
- 2011-11-17 CA CA2818308A patent/CA2818308A1/en not_active Abandoned
- 2011-11-17 CN CN201611167953.2A patent/CN107011333B/zh active Active
-
2013
- 2013-05-16 IL IL226397A patent/IL226397B/en active IP Right Grant
- 2013-05-17 CL CL2013001429A patent/CL2013001429A1/es unknown
- 2013-06-07 CO CO13138546A patent/CO6801635A2/es not_active Application Discontinuation
-
2016
- 2016-11-04 JP JP2016215788A patent/JP6567486B2/ja active Active
- 2016-12-15 US US15/379,969 patent/US10030008B2/en active Active
-
2018
- 2018-07-17 US US16/037,678 patent/US10703743B2/en active Active
-
2020
- 2020-06-05 US US16/894,362 patent/US11136316B2/en active Active
-
2021
- 2021-09-09 US US17/470,393 patent/US11858917B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20140406A1 (es) | Moleculas bifuncionales con actividad de reclutamiento de anticuerpos y actividad inhibitoria inicial contra el virus de la inmunodeficiencia humana | |
| MX377277B (es) | Derivados de fenoximetilo. | |
| EA201791359A1 (ru) | Конъюгаты, связывающие белок-лекарственное средство, содержащие производные антрациклина | |
| EA201591632A1 (ru) | Цитотоксические и антимитотические соединения и способы их применения | |
| EA201691272A1 (ru) | Тетрагидропиридопиразины в качестве модуляторов gpr6 | |
| EA201591497A1 (ru) | Новые производные октагидропирроло[3,4-c]пиррола и их аналоги в качестве ингибиторов аутотаксина | |
| EA201492223A1 (ru) | Новые диазаспироциклоалканы и азаспироциклоалканы | |
| MY169043A (en) | New dihydroquinoline-2-one derivatives | |
| EA201001205A1 (ru) | Соединения, содержащие циклобутоксигруппу | |
| EA201100299A1 (ru) | Органические соединения | |
| EA201170772A1 (ru) | Органические соединения | |
| EA200901612A1 (ru) | Противовоспалительные соединения замещенных циклобутендионов | |
| MY153915A (en) | Organic compounds | |
| ECSP11010880A (es) | Compuestos orgánicos | |
| CY1119220T1 (el) | Μονοκυκλικο παραγωγο πυριδινης | |
| MX386063B (es) | Compuesto de pirrolidina novedoso, y aplicación como agonista del receptor de melanocortina. | |
| CY1122441T1 (el) | Καινοτομες ενωσεις και συζευγματα κρυπτοφυκινης, η παρασκευη τους και η θεραπευτικη χρηση τους | |
| MY169267A (en) | New aryl-quinoline derivatives | |
| MX2015001099A (es) | Nuevos derivados biciclicos de piridina. | |
| BR112014030474A2 (pt) | novos compostos bicíclicos de tiofenilamida | |
| MX364069B (es) | Moduladores de la proteína activadora de 5-lipoxigenasa. | |
| EA201190293A1 (ru) | Пролекарства триптолида | |
| EA201170997A1 (ru) | Производные индола в качестве противораковых агентов | |
| EA201691982A1 (ru) | 5,6-дизамещенные пиридин-2-карбоксамиды в качестве агонистов каннабиноидных рецепторов | |
| CY1123722T1 (el) | Ενεσιμα φαρμακευτικα σκευασματα λεφαμουλινης |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |